Advyzon Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Sell
20,120
-534
-3% -$62.5K 0.19% 120
2026
Q1
$2.48M Buy
20,654
+1,565
+8% +$181K 0.22% 107
2025
Q4
$2.01M Buy
19,089
+6,883
+56% +$646K 0.23% 104
2025
Q3
$1.02M Buy
12,206
+3,073
+34% +$253K 0.18% 125
2025
Q2
$723K Buy
9,133
+453
+5% +$36K 0.16% 127
2025
Q1
$779K Buy
8,680
+1,248
+17% +$117K 0.28% 73
2024
Q4
$739K Buy
+7,432
New +$766K 0.29% 71

Other funds holding MRK

Advyzon Investment Management's MRK Position: Q2 2026 in Review

Advyzon Investment Management reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $62.5K and leaving 20,120 shares worth $2.59M. The position accounts for 0.19% of the portfolio, ranked #120.

Advyzon Investment Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Advyzon Investment Management held 20,120 shares of Merck worth $2.59M as of Q2 2026.
  • Advyzon Investment Management sold 534 Merck shares in Q2 2026, an estimated $62.5K.
  • Merck made up 0.19% of Advyzon Investment Management's portfolio in Q2 2026, its #120 holding.
  • Advyzon Investment Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.